Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Read about our new masking policy »

Prevention

The Stanford Health Care Center for Memory Disorders is encouraged that there is a new treatment option for certain patients with Alzheimer’s disease. On January 6, 2023, the FDA granted accelerated approval for lecanemab (LeqembiTM). 

Learn more»

Prevention of Alzheimer's Disease

Because the cause of the disease is unknown, there are no prevention protocols to follow at this time. And, because the controllable risk factors for Alzheimer's disease are not clear, it is not yet possible to reduce the chances of developing the disease. Exercise, social interaction and intellectual stimulation can help slow cognitive decline.

Clinical Trials

0

Open Clinical Trials

View All »

Open trials refer to studies currently recruiting participants or that may recruit participants in the near future. Closed trials are not currently enrolling, but similar studies may open in the future.

Closed trials are not currently enrolling, but may open in the future.

Condition Spotlight

  1. The Latest on Alzheimer's Disease Research The Latest on Alzheimer's Disease Research
    Watch Video
    When Fading Memory Raises Questions, Neuropsychology Can Point to Answers When Fading Memory Raises Questions, Neuropsychology Can Poin...
    Watch Video
    Your Health: Alzheimer's Disease & Dementia Your Health: Alzheimer's Disease & Dementia
    Watch Video

Our Clinics

See a Stanford specialist to learn about your treatment options. Visit one of our clinics to make an appointment.

300 Pasteur Drive
 HC034
 Stanford, CA 94305
Phone: 650-723-1303
213 Quarry Road
 Palo Alto, CA 94304
213 Quarry Road
 Palo Alto, CA 94304
Phone: 650-723-7181